The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

Unlike many other diseases, cancer care is uniquely complex, involving prolonged treatment regimens, high costs, and ...

New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.

The Decipher Bladder Genomic Subtyping Classifier found that patients with luminal tumors may have less aggressive disease.

The Montana Supreme Court has upheld a District Court judge’s ruling in favor of St. Peter’s Health against Helena oncologist ...

New, less damaging treatments are giving some patients the choice to try to preserve their ability to have children after ...

We take submissions each year for women making a difference and impact in our community, and it is time to start showing them off! Today we highlighted Kathy Daugherty! Kathy is a Chemotherapy ...

The breakthrough in drug delivery hinges on the development of nanoarchaeosomes, which are nanoparticles loaded with ...

Burjeel Cancer Institute (BCI) has expanded its reach by opening a new centre at Burjeel Hospital Al Ain. This strategic ...

Stem cell transplants play a vital role in treating people affected by blood cancers and disorders such as thalassemia.

Pfizer & Astellas’ Padcev plus Keytruda shows long-term efficacy in first-line treatment of locally advanced or metastatic urothelial cancer: New York Wednesday, February 12, 20 ...